1887

Abstract

Simian varicella virus (SVV) causes a varicella-like disease in non-human primates. In this study, SVV virions were purified from SVV-infected BSC-1 cells by zonal and differential gradient centrifugation and the virion polypeptide composition was analysed by SDS-PAGE. SVV virions had a buoyant density of 1.21 g/ml, identical to the value obtained for varicella-zoster virus (VZV) virions purified by the same method. Electron microscopy of the concentrated SVV virions revealed characteristic herpesvirus morphology. SVV virions consisted of at least 30 polypeptide species ranging from 16K to >200K. The electrophoretic profiles of radiolabelled SVV and VZV virion polypeptides were very similar. Immunoprecipitations of solubilized SVV-infected cell preparations using SVV immune sera revealed at least 18 viral polypeptides with an range of 12K to 142K and six glycoproteins ranging from 46K to 115K. In addition, extensive cross-reactivity between SVV and VZV proteins and glycoproteins was demonstrated by immunoprecipitation with heterologous immune sera. The high degree of antigenic relatedness between SVV and VZV provides further support for simian varicella as a model for VZV infections.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-5-1209
1992-05-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/5/JV0730051209.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-5-1209&mimeType=html&fmt=ahah

References

  1. Allen W. P., Felsenfeld A. D., Wolf R. H., Smetana H. F. 1974; Recent studies on the isolation and characterization of Delta herpesvirus. Laboratory Animal Science 24:222–228
    [Google Scholar]
  2. Arvin A. M., Martin D. P., Gard E. A., Merigan T. C. 1983; Interferon prophylaxis against simian varicella in Erythrocebus patas monkeys. Journal of Infectious Diseases 147:149–154
    [Google Scholar]
  3. Ayres J. P. 1971; Studies of the Delta herpesvirus isolated from the patas monkey (Erythrocebus patas). Laboratory Animal Science 21:685–695
    [Google Scholar]
  4. Balachandran N., Oba D. E., Hutt-Fletcher L. M. 1987; Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus. Journal of Virology 61:1125–1135
    [Google Scholar]
  5. Blakely G. A., Lourie B., Morton W. G., Evans H. H., Kaufmann A. F. 1973; A varicella-like disease in macaque monkeys. Journal of Infectious Diseases 127:617–625
    [Google Scholar]
  6. Clarkson M. J., Thorpe E., McCarthy K. 1967; A virus disease of captive vervet monkeys Cercopithicus aethiops caused by a new herpes virus. Archiv fur die Gesamte Virusforschung 22:219–234
    [Google Scholar]
  7. Davison A. J., Scott J. E. 1986; The complete DNA sequence of varicella-zoster virus. Journal of General Virology 67:1759–1816
    [Google Scholar]
  8. Davison A. J., Edson C. M., Ellis R. W., Forghani B., Gilden D., Grose C., Keller P. M., Vafai A., Wroblewska Z., Yamanishi K. 1986; New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. Journal of Virology 57:1195–1197
    [Google Scholar]
  9. Eberle R., Mou S. W. 1983; Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera. Journal of Infectious Diseases 148:436–444
    [Google Scholar]
  10. Eberle R., Black B., Hilliard J. K. 1989; Relatedness of glycoproteins expressed on the surface of simian herpesvirus virions and infected cells to specific HS V glycoproteins. Archives of Virology 109:233–252
    [Google Scholar]
  11. Felsenfeld A. D., Schmidt N. J. 1975; Immunological relationship between Delta herpesvirus of patas monkeys and varicella-zoster virus of humans. Infection and Immunity 12:261–266
    [Google Scholar]
  12. Felsenfeld A. D., Schmidt N. J. 1977; Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus. Infection and Immunity 15:807–812
    [Google Scholar]
  13. Felsenfeld A. D., Schmidt N. J. 1979; Varicella-zoster virus immunizes patas monkeys against simian varicella-like disease. Journal of General Virology 42:171–178
    [Google Scholar]
  14. Forghani B., Dupuis K. W., Schmidt N. J. 1990; Epitopes functional in neutralization of varicella-zoster virus. Journal of Clinical Microbiology 28:2500–2506
    [Google Scholar]
  15. Gelb L. D. 1985; Varicella-zoster virus. In Virology pp 591–627 Edited by Fields B. N., Knipe D. M., Chanock R. M., Melnick J. L., Roizman B., Shope R. E. New York: Raven Press;
    [Google Scholar]
  16. Gray W. L., Oakes J. E. 1984; Simian varicella virus DNA shares homology with human varicella-zoster virus DNA. Virology 136:241–246
    [Google Scholar]
  17. Gray W. L., Pumphrey C. Y., Ruyechan W. T., Fletcher T. M. 1992; The simian varicella virus and varicella-zoster virus genomes are similiar in size and structure. Virology (in press)
    [Google Scholar]
  18. Grose C. 1990; Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annual Review of Microbiology 44:59–80
    [Google Scholar]
  19. Kessler S. W. 1981; Use of Protein A-bearing staphylococci for the immunoprecipitation and isolation of antigens from cells. Methods in Enzymology 73:442–459
    [Google Scholar]
  20. Kuhn J. E., Klaffke K., Munk K., Braun R. W. 1990; HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Archives of Virology 112:203–213
    [Google Scholar]
  21. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680684
    [Google Scholar]
  22. Lake-Bakaar D. M., Abele G., Lindborg B., Soike K. F., Datema R. 1988; Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R, S)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, an anti-varicella zoster drug. Antimi-crobial Agents and Chemotherapy 32:1807–1812
    [Google Scholar]
  23. McCarthy K., Thorpe E., Laursen A. C., Heymann C. S., Beale A. J. 1968; Exanthematous disease in patas monkeys caused by a herpes virus. Lancet ii:856–857
    [Google Scholar]
  24. Mahalingam R., Smith D., Wellish M., Wolf W., Dueland A. N., Cohrs R., Soike K., Gilden D. 1991; Simian varicella virus DNA in dorsal root ganglia. Proceedings of the National Academy of Sciences, U.S.A. 88:2750–2752
    [Google Scholar]
  25. Padovan D., Cantrell C. A. 1986; Varicella-like herpesvirus infections of nonhuman primates. Laboratory Animal Science 36:7–13
    [Google Scholar]
  26. Riopelle A. J., Ayres J. P., Siebold H. R., Wolf R. H. 1970; Studies on primate diseases at the Delta Center. In Medical Primatology pp 826–838 Edited by Goldsmith E. I., Moor-Jankowski J. White Plains, New York: Albert Phiebig;
    [Google Scholar]
  27. Shemer Y., Leventon-Kriss S., Sarov I. 1980; Isolation and polypeptide characterization of varicella-zoster virus. Virology 106:133–140
    [Google Scholar]
  28. Soike K. F., Keller P. M., Ellis R. W. 1987; Immunization of monkeys with varicella-zoster virus glycoprotein antigens and their response to challenge with simian varicella virus. Journal of Medical Virology 22:307–313
    [Google Scholar]
  29. Soike K. F., Chou T. C., Fox J. J., Watanabe K. A., Gloff C. A. 1990; Inhibition of simian varicella virus infection of monkeys by 1 -(2-deoxy-2-fluoro-1 -β-D-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-β. Antiviral Research 13:165–174
    [Google Scholar]
  30. Spear P. G. 1984; Glycoproteins specified by herpes simplex viruses. In The Herpesviruses vol 3 pp 315–356 Edited by Roizman B. New York: Plenum Press;
    [Google Scholar]
  31. Stinski M. F. 1990; Cytomegalovirus and its replication. In Virology 2nd edn., vol 2 pp 1959–2010 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  32. Takasaka M., Sakakibara I., Mukai R., Suzuki M. 1990; An outbreak of nonhuman primate varicella-like herpesvirus infection in the established breeding colony of cynomolgus monkeys. Tsukuba Primate Center News 9:5–11
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-5-1209
Loading
/content/journal/jgv/10.1099/0022-1317-73-5-1209
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error